vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and YORK WATER CO (YORW). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $19.4M, roughly 1.1× YORK WATER CO). YORK WATER CO runs the higher net margin — 26.7% vs -373.3%, a 400.0% gap on every dollar of revenue.
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
The York Water Company is an investor-owned, public utility company based in York, Pennsylvania and operating throughout Pennsylvania. The company was founded in 1816 by a group of local businessmen concerned about fire protection.
AUTL vs YORW — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $19.4M |
| Net Profit | $-79.1M | $5.2M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | 33.2% |
| Net Margin | -373.3% | 26.7% |
| Revenue YoY | — | 3.2% |
| Net Profit YoY | 3.6% | 0.5% |
| EPS (diluted) | $-0.30 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $19.4M | ||
| Q3 25 | $21.2M | $20.2M | ||
| Q2 25 | $20.9M | $19.1M | ||
| Q1 25 | $9.0M | $18.3M | ||
| Q4 24 | — | $18.8M | ||
| Q3 24 | $0 | $19.6M | ||
| Q2 24 | $0 | $18.6M | ||
| Q1 24 | $10.1M | $17.5M |
| Q4 25 | — | $5.2M | ||
| Q3 25 | $-79.1M | $6.2M | ||
| Q2 25 | $-47.9M | $5.1M | ||
| Q1 25 | $-70.2M | $3.6M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | $-82.1M | $5.9M | ||
| Q2 24 | $-58.3M | $5.0M | ||
| Q1 24 | $-52.7M | $4.3M |
| Q4 25 | — | 33.2% | ||
| Q3 25 | -337.9% | 39.1% | ||
| Q2 25 | -292.6% | 37.1% | ||
| Q1 25 | -726.3% | 34.3% | ||
| Q4 24 | — | 35.8% | ||
| Q3 24 | — | 41.1% | ||
| Q2 24 | — | 37.9% | ||
| Q1 24 | -384.1% | 35.5% |
| Q4 25 | — | 26.7% | ||
| Q3 25 | -373.3% | 30.6% | ||
| Q2 25 | -229.0% | 26.5% | ||
| Q1 25 | -781.1% | 19.8% | ||
| Q4 24 | — | 27.4% | ||
| Q3 24 | — | 29.9% | ||
| Q2 24 | — | 26.8% | ||
| Q1 24 | -522.1% | 24.7% |
| Q4 25 | — | $0.36 | ||
| Q3 25 | $-0.30 | $0.43 | ||
| Q2 25 | $-0.18 | $0.35 | ||
| Q1 25 | $-0.26 | $0.25 | ||
| Q4 24 | — | $0.36 | ||
| Q3 24 | $-0.31 | $0.41 | ||
| Q2 24 | $-0.22 | $0.35 | ||
| Q1 24 | $-0.24 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $1.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $240.3M |
| Total Assets | $661.9M | $680.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.0K | ||
| Q3 25 | $86.1M | $1.0K | ||
| Q2 25 | $123.8M | $1.0K | ||
| Q1 25 | $95.8M | $1.0K | ||
| Q4 24 | — | $1.0K | ||
| Q3 24 | $657.1M | $1.0K | ||
| Q2 24 | $705.9M | $1.0K | ||
| Q1 24 | $758.5M | $3.3M |
| Q4 25 | — | $240.3M | ||
| Q3 25 | $265.5M | $238.0M | ||
| Q2 25 | $346.5M | $234.6M | ||
| Q1 25 | $371.1M | $232.1M | ||
| Q4 24 | — | $231.2M | ||
| Q3 24 | $477.0M | $228.7M | ||
| Q2 24 | $527.8M | $225.4M | ||
| Q1 24 | $582.0M | $222.9M |
| Q4 25 | — | $680.9M | ||
| Q3 25 | $661.9M | $667.1M | ||
| Q2 25 | $721.0M | $653.7M | ||
| Q1 25 | $746.3M | $641.8M | ||
| Q4 24 | — | $633.5M | ||
| Q3 24 | $827.5M | $621.4M | ||
| Q2 24 | $853.6M | $610.4M | ||
| Q1 24 | $901.4M | $602.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $8.4M |
| Free Cash FlowOCF − Capex | $-72.3M | — |
| FCF MarginFCF / Revenue | -341.2% | — |
| Capex IntensityCapex / Revenue | 20.8% | — |
| Cash ConversionOCF / Net Profit | — | 1.63× |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.4M | ||
| Q3 25 | $-67.9M | $7.8M | ||
| Q2 25 | $-72.8M | $7.6M | ||
| Q1 25 | $-75.6M | $6.0M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | $-76.7M | $7.5M | ||
| Q2 24 | $-51.1M | $6.7M | ||
| Q1 24 | $-40.5M | $6.1M |
| Q4 25 | — | — | ||
| Q3 25 | $-72.3M | — | ||
| Q2 25 | $-80.1M | — | ||
| Q1 25 | $-83.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-86.3M | — | ||
| Q2 24 | $-51.9M | — | ||
| Q1 24 | $-41.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | -341.2% | — | ||
| Q2 25 | -382.6% | — | ||
| Q1 25 | -933.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -406.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 20.8% | — | ||
| Q2 25 | 34.8% | — | ||
| Q1 25 | 91.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | — | 1.63× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 1.50× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.98× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 1.34× | ||
| Q1 24 | — | 1.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
